Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFα reduce colitis-associated colorectal carcinogenesis?. Issue 12 (18th November 2009) - Biancone, L; Petruzziello, C; Calabrese, E; Zorzi, F; Naccarato, P; Onali, S; Pallone, F